Relay Therapeutics (RLAY) Change in Cash (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly Change in Cash of $120.6 million for Q1 2026, up 492.16% year-over-year from $20.4 million in Q1 2025, and up 1523.84% quarter-over-quarter from -$8.5 million in Q4 2025.
Relay Therapeutics (RLAY) Change in Cash (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Change in Cash for 8 consecutive years, with $120.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 492.16% year-over-year to $120.6 million; the TTM figure through Mar 2026 stood at $110.3 million (up 284.04% YoY), while the FY2025 annual figure was -$41.1 million, down 104.88% from the prior year.
- Change in Cash grew to $120.6 million in Q1 2026 per RLAY's latest filing, from -$8.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $246.9 million in Q3 2022 and bottomed at -$202.8 million in Q4 2022.
- Historically, Change in Cash has averaged -$4.5 million across 5 years, with a median of -$8.5 million in 2025.
- On a YoY basis, Change in Cash climbed as much as 883.58% in 2022 and fell as far as 1131.23% in 2022.
- Relay Therapeutics' Change in Cash stood at -$202.8 million in 2022, then jumped by 96.26% to -$7.6 million in 2023, then plunged by 269.73% to -$28.1 million in 2024, then jumped by 69.83% to -$8.5 million in 2025, then soared by 1523.84% to $120.6 million in 2026.
- Business Quant data shows RLAY's Change in Cash at $120.6 million in Q1 2026, -$8.5 million in Q4 2025, and -$22.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | -83.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -83.40 Mn |
| Mar 31, 2026 | 120.57 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | -22.38 Mn |
| Jun 30, 2025 | 20.54 Mn |
| Mar 31, 2025 | -30.75 Mn |
| Dec 31, 2024 | -28.07 Mn |
| Sep 30, 2024 | 17.64 Mn |
| Jun 30, 2024 | -18.74 Mn |
| Mar 31, 2024 | 9.13 Mn |
| Dec 31, 2023 | -7.59 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | -15.24 Mn |
| Mar 31, 2023 | 9.48 Mn |
| Dec 31, 2022 | -202.85 Mn |
| Sep 30, 2022 | 246.91 Mn |
| Jun 30, 2022 | -11.71 Mn |
| Mar 31, 2022 | -160.67 Mn |
| Dec 31, 2021 | 51.56 Mn |
| Sep 30, 2021 | -31.51 Mn |